Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-23-043278

Options or other derivatives

  • Chief Medical Officer acquired 82,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Levisetti Matteo Chief Medical Officer 2023-07-21 Grant or award · Stock Option (right to buy) +82,500 82,500 D: show line 1 in the form
Loading xslF345X05/doc4.xml…